These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29385698)

  • 1. Theoretical and Experimental Studies on Inclusion Complexes of Pinostrobin and β-Cyclodextrins.
    Kicuntod J; Sangpheak K; Mueller M; Wolschann P; Viernstein H; Yanaka S; Kato K; Chavasiri W; Pongsawasdi P; Kungwan N; Rungrotmongkol T
    Sci Pharm; 2018 Jan; 86(1):. PubMed ID: 29385698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion complexation of pinostrobin with various cyclodextrin derivatives.
    Kicuntod J; Khuntawee W; Wolschann P; Pongsawasdi P; Chavasiri W; Kungwan N; Rungrotmongkol T
    J Mol Graph Model; 2016 Jan; 63():91-8. PubMed ID: 26709752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
    Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
    J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aurisin A Complexed with 2,6-Di-
    Charoenwongpaiboon T; Oo A; Nasoontorn S; Rungrotmongkol T; Kanokmedhakul S; Mahalapbutr P
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexation of morin with three kinds of cyclodextrin. A thermodynamic and reactivity study.
    Jullian C; Orosteguis T; Pérez-Cruz F; Sánchez P; Mendizabal F; Olea-Azar C
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Nov; 71(1):269-75. PubMed ID: 18262835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
    Aleem O; Kuchekar B; Pore Y; Late S
    J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, Physicochemical Characterization and I n - vitro Dissolution Studies of Diosmin-cyclodextrin Inclusion Complexes.
    Ai F; Ma Y; Wang J; Li Y
    Iran J Pharm Res; 2014; 13(4):1115-23. PubMed ID: 25587299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Liu L; Zhu S
    J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diloxanide furoate binary complexes with β-, methyl-β-, and hydroxypropyl-β-cyclodextrins: inclusion mode, characterization in solution and in solid state and in vitro dissolution studies.
    Aloisio C; Longhi M
    Pharm Dev Technol; 2018 Sep; 23(7):723-731. PubMed ID: 28758845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectroscopic characterization of the inclusion complexes of luteolin with native and derivatized beta-cyclodextrin.
    Jullian C; Cifuentes C; Alfaro M; Miranda S; Barriga G; Olea-Azar C
    Bioorg Med Chem; 2010 Jul; 18(14):5025-31. PubMed ID: 20576438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies.
    Phillip Lee YH; Sathigari S; Jean Lin YJ; Ravis WR; Chadha G; Parsons DL; Rangari VK; Wright N; Babu RJ
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1113-20. PubMed ID: 19640249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the dermal anti-inflammatory, antioxidant, and analgesic activity of pinostrobin.
    González AS; Soto Tellini VH; Benjumea Gutiérrez DM
    Heliyon; 2022 Sep; 8(9):e10413. PubMed ID: 36097473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling.
    Adhikari S; Daftardar S; Fratev F; Rivera M; Sirimulla S; Alexander K; Boddu SHS
    Int J Pharm; 2018 Jul; 545(1-2):357-365. PubMed ID: 29747001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Solubility and Anticancer Potential of Mansonone G By β-Cyclodextrin-Based Host-Guest Complexation: A Computational and Experimental Study.
    Mahalapbutr P; Wonganan P; Charoenwongpaiboon T; Prousoontorn M; Chavasiri W; Rungrotmongkol T
    Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31569832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
    Pralhad T; Rajendrakumar K
    J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of inclusion complexes formed between baicalein and cyclodextrins.
    Zhou Q; Wei X; Dou W; Chou G; Wang Z
    Carbohydr Polym; 2013 Jun; 95(2):733-9. PubMed ID: 23648035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supramolecular structure of glibenclamide and β-cyclodextrins complexes.
    Lucio D; Irache JM; Font M; Martínez-Ohárriz MC
    Int J Pharm; 2017 Sep; 530(1-2):377-386. PubMed ID: 28779983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-cyclodextrin complexes of celecoxib: molecular-modeling, characterization, and dissolution studies.
    Reddy MN; Rehana T; Ramakrishna S; Chowdhary KP; Diwan PV
    AAPS PharmSci; 2004 Mar; 6(1):E7. PubMed ID: 15198508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
    Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.